You are here: Home » Blog » Blue Chip Blog » What is Reactive Hyperemia and Why it’s Important for Wound Care

What is Reactive Hyperemia and Why it’s Important for Wound Care

A Technical Overview for Clinicians, Hospitals, and Wound Care Professionals

Jump Links

• Clinical Summary
• What Is Reactive Hyperemia?
• Why Reactive Hyperemia Matters in Wound Care
• Clinical Deep Dive: What Causes Reactive Hyperemia?
• Reactive Hyperemia vs. Stage 1 Pressure Injury
• Clinical Workflow: What to Do When You Observe Reactive Hyperemia
• Why Support Surfaces Matter
• Clinical Data & Key Thresholds
• Frequently Asked Questions

Clinical Summary

Reactive hyperemia is a localized increase in blood flow that occurs after pressure is relieved from tissue. It is a normal physiological response indicating that temporary ischemia has occurred. In healthy tissue, this response is brief and resolves quickly. However, prolonged or abnormal reactive hyperemia may signal impaired tissue tolerance and an increased risk of pressure injury. Differentiating between transient hyperemia and early-stage tissue damage is critical in clinical assessment and intervention.

What Is Reactive Hyperemia?

Reactive hyperemia is the body’s response to periods of inadequate blood supply to a tissue or organ, such as the skin. This phenomenon in wound care refers to an increase in blood circulation in the small arteries and capillaries after the skin has experienced a temporary obstruction in blood flow. Obstruction in blood supply to the skin occurs from prolonged unrelieved pressure between the body and the support surface (ie wheelchair or recliner seat, mattress or more). This often results in pressure-related injuries, especially for those who are less mobile and are unable to reposition.

When blood flow to the skin is reduced or completely obstructed, certain metabolic changes occur within the skin. These changes include the accumulation of metabolic byproducts like carbon dioxide, lactate, and adenosine, as well as the depletion of oxygen and nutrients. Prolonged depletion of oxygen and nutrients in the skin cells causes the skin cells to malfunction and eventually die.

Reactive hyperemia occurs when the obstruction to blood flow is removed or reduced. This allows vital oxygen and nutrients to reach the affected skin.

An example in its simplest form,
Picture a garden hose. Pinch off a garden hose with a thumb, creating an obstruction in the flow. Maintain the obstruction for 30 seconds and then release the pressure. The result is an initial pulse of water. When applied to the skin, the sudden restoration of blood flow exceeds normal levels in the affected area. In wound care, Alternating Pressure therapy with its timed cycles of “alternating pressure” is based on Reactive Hyperemia. Slight pressure applied to the skin, once released, forces an increased flow of blood into the skin. This increase in blood flow compensates for the oxygen and nutrient debt incurred during the period of reduced blood supply.

In addition to the physical forces that increase blood flow, there is a complex interplay of metabolic factors and cell signaling that enables rapid, increased restoration of blood supply.

The accumulation of metabolic byproducts during the lack of blood flow triggers the body to respond. One such byproduct, adenosine, stimulates the release of vasodilator substances such as nitric oxide (NO). Nitric Oxide causes the relaxation of the smooth muscle cells in the blood vessel wall (Endothelial cells). When the blood vessel wall relaxes it opens/dilates allowing more blood to flow to the affected skin. The increased blood flow delivers vital oxygen, nutrients required for skin health, and is essential for healing of pressure wounds.

Reactive hyperemia serves as an essential physiological mechanism to restore proper blood flow and is crucial for prevention and treatment of pressure wounds.

Why Reactive Hyperemia Matters in Wound Care

Reactive hyperemia plays a central role in the early detection and prevention of pressure injuries. It is often one of the first visible indicators that tissue has been exposed to sustained mechanical loading and reduced perfusion.

When pressure exceeds the tolerance of capillary structures, localized ischemia occurs. The body’s compensatory response—reactive hyperemia—provides insight into whether tissue is recovering normally or progressing toward injury.

Clinically, this makes reactive hyperemia a valuable assessment tool for:

• Identifying early tissue stress
• Evaluating pressure redistribution effectiveness
• Monitoring patient-specific risk factors

Clinical Deep Dive: What Causes Reactive Hyperemia?

At a physiological level, reactive hyperemia is driven by microvascular and biochemical responses to temporary ischemia.

When external pressure exceeds capillary pressure, several processes occur:

• Capillary occlusion reduces blood flow to the affected tissue
• Oxygen delivery decreases while metabolic waste accumulates
• Vasodilatory signals such as nitric oxide are released
• Blood vessels dilate to restore circulation
• Blood flow temporarily exceeds baseline levels

This ischemia-reperfusion response is essential for tissue survival but can become problematic if repeated frequently or sustained over time.

Reactive Hyperemia vs. Stage 1 Pressure Injury

Feature	Reactive Hyperemia	Stage 1 Pressure Injury
Blanching Response	Blanchable	Non-blanchable
Duration	Temporary	Persistent
Tissue Integrity	Intact	Early damage present
Clinical Action	Monitor	Immediate intervention

Accurate differentiation is critical to preventing progression into more severe stages of pressure injury.

Clinical Workflow: What to Do When You Observe Reactive Hyperemia

1. Remove pressure from the affected area
2. Reassess the tissue after a short interval
3. Perform a blanching test
4. Evaluate patient-specific risk factors
5. Adjust support surface strategy if needed
6. Document findings and monitor trends

Why Support Surfaces Matter

Reactive hyperemia is directly influenced by how pressure is applied and relieved over time.

Static surfaces may reduce peak pressure but do not eliminate sustained loading. This can result in repeated cycles of ischemia and reperfusion.

Dynamic support surfaces are designed to:

• Redistribute pressure over time
• Reduce prolonged capillary occlusion
• Support ongoing tissue perfusion

From a clinical perspective, effective pressure management is not just about reducing pressure—it is about preventing sustained ischemia.

Clinical Data & Key Thresholds

• Capillary closing pressure: approximately 32 mmHg
• Tissue damage risk may begin within 2–6 hours of sustained pressure
• Higher risk populations include immobile, elderly, and diabetic patients

These thresholds provide important context for evaluating tissue response and intervention timing.

Frequently Asked Questions

What is reactive hyperemia in wound care?
Reactive hyperemia is a temporary increase in blood flow following a period of reduced circulation, typically observed as redness in the skin after pressure is relieved.

How can you tell the difference between reactive hyperemia and a pressure injury?
Reactive hyperemia is blanchable and resolves quickly, while a pressure injury presents as non-blanchable redness that persists.

How long should reactive hyperemia last?
In healthy tissue, it should resolve within a short period after pressure is removed.

Does reactive hyperemia mean tissue damage has occurred?
Not necessarily. It indicates prior ischemia, but not all cases result in tissue damage.

How do support surfaces affect reactive hyperemia?
They influence how pressure is distributed and relieved, directly impacting tissue perfusion.

What role does pressure redistribution play?
It reduces prolonged exposure to pressure, helping prevent ischemia and tissue damage.

 

IMPORTANT NOTE:
The above are general statements, there are some exceptions. The above is not meant to diagnose or treat any medical condition.
Always seek the advice of a wound care professional.

---

Authored by: Jeff Adise
Jeff has dedicated over 30 years to advancing wound care solutions. He is a product specialist and developer of therapeutic support surfaces for the prevention and treatment of Stage I–IV pressure injuries in hospital beds, home recliners, lift chairs, wheelchairs, and more.